Des-Gamma-Carboxy Prothrombin (DCP), Serum
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Risk assessment of patients with chronic liver disease for development of hepatocellular carcinoma (HCC)
An aid in the monitoring of HCC patients post therapy if des-gamma-carboxy prothrombin (DCP) level was elevated prior to therapy. An elevated DCP level is associated with increased risk of recurring HCC.
Isotachophoresis with Laser-Induced Fluorescence
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Des-Gamma-Carboxy Prothrombin, S